CCL18 and breast carcinoma: To further validate that CCL18 reduces the expression of the above miRNAs in breast cancer cells, we performed qRT-PCR to determine the levels of miR98 and miR27b in MCF-7 and MDA-MB-231 cells after treatment with CCL18 at various concentrations for 24 hr.